Does UPADACITINIB Cause Chronic obstructive pulmonary disease? 195 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 195 reports of Chronic obstructive pulmonary disease have been filed in association with UPADACITINIB (Rinvoq). This represents 0.3% of all adverse event reports for UPADACITINIB.
195
Reports of Chronic obstructive pulmonary disease with UPADACITINIB
0.3%
of all UPADACITINIB reports
15
Deaths
112
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From UPADACITINIB?
Of the 195 reports, 15 (7.7%) resulted in death, 112 (57.4%) required hospitalization.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 195 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)
Which UPADACITINIB Alternatives Have Lower Chronic obstructive pulmonary disease Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL